ArticleJournal of biochemical and molecular toxicology2026
SRM 1650b Administration to Isolated Rat Heart Aggravates Ischemia-Reperfusion Injury via Mitochondrial Dysfunction and Downregulation of PI3K/Akt Signaling Pathways.
Article in Journal of biochemical and molecular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SRM 1650b Administration to Isolated Rat Heart Aggravates Ischemia-Reperfusion Injury via Mitochondrial Dysfunction and Downregulation of PI3K/Akt Signaling Pathways.Journal of biochemical and molecular toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Numerous studies have demonstrated an association between diesel particulate matter (DPM) exposure and cardiotoxicity; recent evidence further suggests that cardiomyocytes may directly internalize DPM. In the present study, we investigated the cardiotoxic effects of SRM 1650b, a representative heavy-duty diesel emission particulate standard, which is considered a major contributor to the ongoing air pollution crisis. Isolated male Wistar rat hearts were perfused with different concentrations of SRM 1650b following stabilization, followed by 30 min of ischemia and 60 min of reperfusion. Results demonstrated deteriorated cardiac hemodynamics and elevated tissue injury compared with normal controls across different concentrations of SRM 1650b (HC, highest concentration = 300 μg/mL; MC, medium concentration = 100 μg/mL; LC, low concentration = 10 μg/mL). Administration of SRM 1650b significantly increased oxidative stress in both cardiac tissue and mitochondria. It also induced a decline in mitochondrial bioenergetic enzyme activities and corresponding respiratory efficiency compared with normal controls. The expression of mitochondrial quality-control-associated genes, including Pgc-1α, Tfam, Polg, Fis1, Mfn1, and Pink1, was significantly reduced, along with a decline in mitochondrial DNA copy number. Collectively, these alterations resulted in heightened myocardial sensitivity to ischemia-reperfusion injury. Furthermore, expression of the PI3K/Akt signaling pathway was reduced following SRM 1650b administration and decreased further after ischemia-reperfusion challenge. These findings suggest that SRM 1650b-mediated cardiotoxicity is associated with impaired mitochondrial functional integrity and suppressed PI3K/Akt signaling, thereby reducing the cardiac capacity to withstand ischemia-reperfusion injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.